This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
These Are the Stocks With the Largest Changes in Short Interest in July - GS
Cassava Sciences Granted U.S. Patent US 12065440 B2, Application #17/850198 For "SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS", Filed On 6/27/2022
Biggest Stock Movers Today: PANW, FN, and More
Small-cap and Mid-cap Health Care Has Room to Rally - Roth MKM
Insiders Buying Yum China And 2 Other Stocks
Dyne Therapeutics Analyst Ratings
AnaptysBio Analyst Ratings
Centessa Pharmaceuticals Analyst Ratings
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
Morgan Stanley Maintains Overweight on Dyne Therapeutics, Raises Price Target to $52
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Nurix Therapeutics Analyst Ratings
9 Health Care Stocks Whale Activity In Today's Session
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
Perspective Therapeutics Analyst Ratings
Dyne Therapeutics GAAP EPS of -$0.70 Misses by $0.02
Unveiling 6 Analyst Insights On Kymera Therapeutics
Earnings Summary: Perspective Therapeutics Posts Mixed Q2, Expects Sufficient Funding Till Mid-2026